Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115790 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Denis Lacombe und 3 weiteren Autor:innen. Beteiligte Einrichtung: EORTC Headquarters, Brussels, Belgium. Electronic address: denis.lacombe@eortc.org. Hauptthemen laut MEDLINE: Biomedical Research, Prostatic Neoplasms, Clinical Trials as Topic, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EORTC Headquarters, Brussels, Belgium. Electronic address: denis.lacombe@eortc.org.
- EORTC Headquarters, Brussels, Belgium.
- Cliniques Universitaires Saint Luc, Brussels, Belgium.
Förderung
- European Commission
Zitieren
APA
Lacombe, D., Borges, F., Kromar, S., & Tombal, B. (2025). Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115790
Vancouver
Lacombe D, Borges F, Kromar S, Tombal B. Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115790
BibTeX
@article{Lacombe2025,
author = {Lacombe, Denis and Borges, Fabio and Kromar, Stephanie and Tombal, Bertrand},
title = {Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115790}
}
EUVIMED